-- Mexico Stocks: Genomma Lab, Modelo, OHL Mexico, Sare Are Active
-- B y   P a t r i c i a   L a y a
-- 2012-06-29T15:25:20Z
-- http://www.bloomberg.com/news/2012-06-29/mexico-stocks-genomma-lab-modelo-ohl-mexico-sare-are-active.html
The following companies are having
unusual price changes in Mexico City trading. Stock symbols are
in parentheses, and prices are as of 10:04 a.m. local time.  The  IPC index  rose 1.2 percent to 40,116.34.  Genomma Lab Internacional SAB (LABB)   rose 2.7 percent to
26.31 pesos. The Mexican producer of over-the-counter drugs
acquired 20 brands of  consumer goods , according to a filing
issued yesterday to the Mexican stock exchange. Brands acquired
include Fermodyl haircare products sold in Mexico and the U.S.
and Bioskin skincare products, the company said. It didn’t
disclose financial terms.  Grupo Modelo SAB (GMODELOC)   rose 0.9 percent to 118.85
pesos.  Anheuser-Busch InBev NV (ABI) , the world’s biggest brewer,
agreed to buy the remainder of Mexico’s Grupo Modelo SAB for
$20.1 billion in cash. AB InBev said today it will pay $9.15 a
share, about 30 percent more than the price of Modelo shares
before talks were first disclosed on June 25.  OHL Mexico SAB (OHLMEX*)  , the Mexican unit of Spanish
construction company  Obrascon Huarte Lain SA (OHL) , rose 4.8 percent
to 16.08 pesos. OHL said in an e-mailed statement that its legal
injunction was accepted by a court in the state of Puebla, which
agreed to rule on the legality of a move by the state to
withdraw a concession previously granted to the company.  Sare Holding SAB (SAREB)  , Mexico’s cheapest homebuilder
based on book value, climbed 3.7 percent to 1.42 pesos,
extending its three-day gain to 24 percent. On June 27, Beamonte
Investments Inc.’s managing director Luis Trevino said by phone
from Boston that his private equity firm is considering taking a
stake in Sare.  To contact the reporter on this story:
Patricia Laya in  New York  at 
 playa2@bloomberg.net   To contact the editor responsible for this story:
David Papadopoulos at 
 papadopoulos@bloomberg.net  